New
Rapidemic
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Rapidemic is a developer of diagnostic kits for infectious diseases.
HQ Location
Netherlands
Founded
2020
Employees
1 - 10
Total funding raised
$707.23K
Last Funding Event
Convertible Note, $542.15K, August 31, 2023
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of molecular point-of-care test kits intended to diagnose infectious diseases on the spot. The company's kits utilize a primer technology to detect new airborne infectious diseases and speed up the testing of roaming viruses, enabling clinicians to test infected people anywhere without a laboratory and limited medical facilities and get the results within an hour after the test has been taken.